ISR Projected Dividend Yield

IsoRay, Inc. ( AMEX : ISR )

Perspective Therapeutics through its wholly owned subsidiary IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other diseases. Co.'s primary product is its Cesium-131 sealed source brachytherapy seed. These seeds can be inserted individually or in combination into various locations in the body until the physician is satisfied with the radiation dose delivered. Co. provides technical assistance and selling Cesium-131 brachytherapy seeds for embedding in collagen tiles developed by physicians at Barrow Neurological Institute to treat malignant meningioma, primary brain cancers and metastases of cancers to the brain

20 YEAR PERFORMANCE RESULTS